Earnscliffe has a long history of working with leading industry players, including industry associations, professional expert groups, patient and consumer bodies in biotechnology, pharmaceutical and medical device industries. From start-ups looking for strategic alliances to large firms wanting to strengthen market access.
Decision-makers in healthcare are increasingly searching for economically sustainable approaches and evidence-based decisions. At federal or provincial levels in Canada, or globally, we work with clients to develop and implement tailored strategies to deliver results. Our competitive edge is our deep experience working in-house on cross-functional teams at some of the leading corporations in industry, a record of success in Canada and through our Fipra partners in Europe and around the world, and a keen understanding of what drives government policy, regulatory, pricing and reimbursement decisions in healthcare.